Ian McLeod
Comptroller/Controller/Auditor en ANIKA THERAPEUTICS, INC. .
Perfil
Ian McLeod is currently the Chief Accounting Officer & Vice President at Anika Therapeutics, Inc. He previously worked as a Controller at ABIOMED, Inc. from 2007 to 2017 and as a Corporate Controller at Idenix Pharmaceuticals LLC from 2004 to 2007.
Mr. McLeod has an undergraduate degree from the University of Western Ontario and an MBA from McMaster University.
Cargos activos de Ian McLeod
| Empresas | Cargo | Inicio |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/07/2021 |
Antiguos cargos conocidos de Ian McLeod.
| Empresas | Cargo | Fin |
|---|---|---|
| IDENIX PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01/11/2007 |
| ABIOMED, INC. | Comptroller/Controller/Auditor | - |
Formación de Ian McLeod.
| McMaster University | Masters Business Admin |
| University of Western Ontario | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA. | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Ian McLeod
